Sabyasachi Sanyal

Employment

• Central Drug Research Institute Senior Principal scientist and Professor at AcSIR
  2015 - Present
• CSIR-Central Drug Research Institute Principal Scientist
  2010 - 2015
• CSIR-Central Drug Research Institute Senior Scientist
  2007 - 2010
• Karolinska Institutet Forskare (Post Doctoral Researcher)
  2002 - 2007

Education

• Chonnam National University Ph.D.
  1997 - 2002
• Visva-Bharati University M.Sc.
  1994 - 1996
• Visva-Bharati University B.Sc
  1991 - 1994

Projects & Funding

Projects & funding information is unavailable.

Publications (78)

• Emerging roles of osteocytes in the regulation of bone and skeletal muscle mass
  Journal of Molecular Endocrinology 2025 DOI: 10.1530/JME-24-0033
  +Save
• The role of glucagon-like peptides in osteosarcopenia
  Journal of Endocrinology 2025 DOI: 10.1530/JOE-24-0210
  +Save
• Estradiol overcomes adiponectin-resistance in diabetic mice by regulating skeletal muscle adiponectin receptor 1 expression
  Molecular and Cellular Endocrinology 2021 DOI: 10.1016/j.mce.2021.111525
  +Save
• A butanolic fraction from the standardized stem extract of Cassia occidentalis L delivered by a self-emulsifying drug delivery system protects rats from glucocorticoid-induced osteopenia and muscle atrophy.
  Scientific reports 2020 DOI: 10.1038/s41598-019-56853-6
  +Save
• Long acting GLP-1 analog liraglutide ameliorates skeletal muscle atrophy in rodents.
  Metabolism: clinical and experimental 2019 DOI: 10.1016/j.metabol.2019.154044
  +Save
• CDK2 destabilizes tumor suppressor C/EBPα expression through ubiquitin-mediated proteasome degradation in acute myeloid leukemia.
  Journal of cellular biochemistry 2019 DOI: 10.1002/jcb.29516
  +Save
• Increased bone marrow-specific adipogenesis by clofazimine causes impaired fracture healing, osteopenia and osteonecrosis without extra-skeletal effects in rats.
  Toxicological sciences : an official journal of the Society of Toxicology 2019 DOI: 10.1093/toxsci/kfz172
  +Save
• Leprosy drug clofazimine activates peroxisome proliferator-activated receptor-γ and synergizes with imatinib to inhibit chronic myeloid leukemia cells.
  Haematologica 2019 DOI: 10.3324/haematol.2018.194910
  +Save
• A nutraceutical composition containing diosmin and hesperidin has osteogenic and anti-resorptive effects and expands the anabolic window of teriparatide.
  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2019 DOI: 10.1016/j.biopha.2019.109207
  +Save
• The osteogenic effect of liraglutide involves enhanced mitochondrial biogenesis in osteoblasts
  Biochemical Pharmacology 2019 DOI: 10.1016/j.bcp.2019.03.024
  +Save